Balentine LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,981
| Closed | -$249K | – | 577 |
|
|
2023
Q1 | $249K | Buy |
4,981
+618
| +14% | +$30.9K | 0.01% | 466 |
|
|
2022
Q4 | $202K | Buy |
+4,363
| New | +$202K | 0.01% | 542 |
|
|
2022
Q3 | – | Sell |
-8,013
| Closed | -$299K | – | 618 |
|
|
2022
Q2 | $299K | Sell |
8,013
-4,023
| -33% | -$150K | 0.01% | 431 |
|
|
2022
Q1 | $533K | Buy |
+12,036
| New | +$533K | 0.02% | 280 |
|
|
2021
Q4 | – | Sell |
-4,634
| Closed | -$201K | – | 428 |
|
|
2021
Q3 | $201K | Buy |
+4,634
| New | +$201K | 0.01% | 236 |
|
|
2020
Q3 | – | Sell |
-413
| Closed | -$15K | – | 245 |
|
|
2020
Q2 | $15K | Buy |
413
+151
| +58% | +$5.48K | ﹤0.01% | 446 |
|
|
2020
Q1 | $9K | Sell |
262
-1,738
| -87% | -$59.7K | ﹤0.01% | 381 |
|
|
2019
Q4 | $90K | Buy |
2,000
+1,713
| +597% | +$77.1K | 0.01% | 128 |
|
|
2019
Q3 | $12K | Buy |
287
+84
| +41% | +$3.51K | ﹤0.01% | 305 |
|
|
2019
Q2 | $9K | Buy |
+203
| New | +$9K | ﹤0.01% | 324 |
|
|
2018
Q1 | – | Sell |
-609
| Closed | -$15K | – | 126 |
|
|
2017
Q4 | $15K | Buy |
+609
| New | +$15K | ﹤0.01% | 421 |
|